Bausch + Lomb receives European clearance for SeeLyra surgical laser
Bausch + Lomb ($BLCO) received European CE marking for SeeLyra, a femtosecond laser platform used in the preparation stages of cataract, LASIK-flap and therapeutic corneal procedures. The system combines real-time imaging with a compact design intended to fit existing operating-room arrangements. The company expects limited European availability in the coming months and a broader rollout in 2027. It is also seeking regulatory approvals in other markets, including the United States. European clea
0